NCT06796283Completed
Research on AIS Recurrence Risk Prediction Model Using XGBoost Combined With Convolutional Neural Network Algorithm
Source: ClinicalTrials.gov · Last updated 21 Feb 2025
Brief summary (registry, in English)
The purpose of this observational study is to construct a recurrence risk prediction model for ischemic stroke within 1, 3, 6, and 12 months using XGBoost combined with Convolutional Neural Network (CNN) algorithm. Method: Follow up was conducted on the study subjects at 1, 3, 6, and 12 months after discharge. Follow up primary outcome: Whether the study subjects experienced recurrent stroke events. Secondary outcome: Improved Rinkin score. Collect information on research subjects: It includes demographic data, physical examination, medical history, imaging images, medication use, scale scores, CYP2C19 genotype test results, laboratory tests, and other complex multidimensional data.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 2628 (actual)
- First submitted
- 13 Jan 2025
- Start date
- 26 Apr 2021
- Primary completion date
- 4 Mar 2023
- Lead sponsor
- Second Affiliated Hospital of Nanchang University
- Diseases
- Stroke
- NCT number
- NCT06796283
What you commit to
- Study type: Observational
- Participants enrolled: 2628
- From 26 Apr 2021 to the primary completion date, 4 Mar 2023
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Patients currently participating in any clinical trials related to investigational drugs or medical devices
Other illness
- Patients with cancer
- Patients with hemorrhagic stroke, mixed stroke, and tumor stroke
- Patients with severe heart, lung, or liver system diseases
Other
- Patients with cardiogenic infarction, other causes of cerebral infarction, or cryptogenic cerebral infarction
- Patients judged by the researcher to have poor compliance and unable to complete long-term follow-up
Who the study is looking for
- Aged between 18-85 years
- Diagnosed with ischemic stroke or transient ischemic attack (diagnosis in accordance with the standards set by the Cerebrovascular Disease Group of the Neurology Branch of the Chinese Medical Association in 2014)
- Within the acute phase of the illness (within 2 weeks)
- Voluntarily participates and signs an informed consent form
Age in the registry: 18 years to 85 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| The Second Affiliated Hospital of Nanchang University Coordinator of this site? Confirm its status | Nanchang | China | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.